Curasan AG

Booth number 10E39

curasan AG is a leading German manufacturer in regenerative medicine. Our stypro offers fast hemostasis, a high absorbent potential, optimal porosity and interconnection.

About us

Since end of September 2020 curasan AG is a non-listed stock corporation. Curasan AG is a leading German manufacturer in regenerative medicine. Our stypro hemostyptic is used in major Chinese hospitals in surgery and dentistry. Stypro offers fast hemostasis , has a high absorbent potential up to 35 times of its own weight, has optimal porosity and interconnection and is resorbable and implantable. It is available in different sizes to fit the needs of different surgical departments. curasan´s innovative products are cleared by the US Food and Drug Administration (FDA) and many other international authorities and available in almost 50 countries worldwide. Numerous patents and a broad record of scientific publications demonstrate the clinical success of curasan´s highly innovative products. As exclusive distribution partner in China, Beijing Bicom Tc Company presents curasan´s innovative solutions for tissue enigineering, wound healing and hemostasis.

Curasan AG
Lindigstr. 4
63801 Kleinostheim

Phone: +49 6027 4090032
Fax: +49 6027 4090049

Beijing BiComTc Medical Instruments Company
Room 1001, Floor 10, Unit 3, Building 1, No. 20 YongAn Road, ShiLong Economic Development Zone, MenTouGou district
P. R. China

Phone: +86 10 59203738
Fax: +86 10 59203793

Products and Services

stypro ®  has:

a high capacity of absorption of liquids (up to 35 times its weight) 
a rapid haemostatic effect 
an optimal interconnecting porosity 
an excellent tolerance and biocompatibility, no exogenous thrombin is needed

Click here if you notice an image that violates copyright or privacy rights.

Get in contact

We only use functionally necessary cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection